Ads
    Related paper
  1. Atherogenic Dyslipidemia: An Important Risk Factor for Cardiovascular Disease in Metabolic Syndrome and Type 2 Diabetes Mellitus Patients
  2. Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
  3. Postprandial Dyslipidemia: Emerging lipid profile for cardiovascular disease risk in Type 2 Diabetes Mellitus subjects: A case control study. J Pharm Biomed Sci. 2015; 05(06):491-498
  4. A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus
  5. LIPID HOMEOSTASIS PECULARITIES IN ISCHEMIC HEART DISEASE PATIENTS WITH HEART FAILURE SYMPTOMS, DIABETES MELLITUS 2 TYPE AND METABOLIC SYNDROME DEPENDING ON MEDICATION PECULIARITIES
  6. AN EXPERIENCE OF USING SIMVASTATINUM IN THE METABOLIC SYNDROME OF PATIENTS WITH CHRONIC CHOLECYSTITIS AND DIABETES MELLITUS TYPE II
  7. GLYCOSYLATED HEMOGLOBIN AS A RISK ASSESSMENT OF THE CARDIOVASCULAR LESIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
  8. Administration of Tadalafil to Patients with Type 2 Diabetes Mellitus and Metabolic Syndrome: A Prospective Randomized Clinical Trial
  9. Epidemiological and Metabolic Aspects and Risk Factors of Chronic Kidney Disease in Comorbid Pathology of Type 2 Diabetes Mellitus and Primary Hypothyroidism
  10. The Association between Left Ventricular Myocardial Strains and Risk Factors of Cardiovascular Disease in a Population with Type 2 Diabetes Mellitus: A Primary Controlled Cross-Sectional Study